Skip to main content

Table 1 Details of patient characteristics

From: Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors

No.

Age

Sex

Primary site

Subject

Histology of target lesion

Chronic Lung Disorder

Inoperable reason

K-PS (%)

s KL (U/ml)

s SP-D (ng/ml)

VC (L)

FEV1.0 (L)

1

75

M

lung

primary

Adenoca

No

reject

90

wnl

wnl

4.07

2.81

2

83

M

lung

primary

Unknown

No

TAA/IHD

90

wnl

wnl

NA

NA

3

50

F

rectum

metastasis

Adenoca

post lobectomy

rectal ca.

90

wnl

wnl

3.40

2.66

4

77

M

lung

recurrence

SCLC

emphysema

SCLC-ED

90

wnl

wnl

NA

NA

5

75

M

lung

primary

Adenoca

No

nephrotic syndrome

80

wnl

wnl

NA

NA

6

60

M

lung

metastasis

Adenoca

post lobectomy

metastasis

90

743

wnl

2.61

0.59

7

79

M

lung

primary

SqCC

emphysema

colon ca./prostate ca.

90

wnl

wnl

1.75

1.26

8

79

M

ampulla of Vater

metastasis

Unknown

No

metastasis

80

wnl

wnl

NA

NA

9

69

M

lung

recurrence

Aenoca

post partial resection

recurrence

90

wnl

wnl

NA

NA

10

84

M

lung

primary

SqCC

No

TAA

70

wnl

wnl

1.74

0.85

11

81

M

lung

primary

Adenoca

No

M valve replacement

80

wnl

wnl

3.19

2.30

12

82

M

lung

primary

SqCC

No

prostate ca.

80

wn

wn

2.50

1.75

13

72

M

lung

metastasis

SqCC

No

metastasis

80

950

NA

2.76

2.13

14

80

M

lung

primary

Unknown

emphysema

HCC/colon ca.

80

NA

NA

NA

NA

15

80

M

kidney

metastasis

Unknown

No

Renal cell carcinoma

80

529

wnl

NA

NA

16

60

M

lung

metastasis

Carcinoma

IP

metastasis

80

852

NA

4.01

3.24

17

77

M

lung

primary

NSCLC

IP

IP

80

1590

NA

3.05

1.59

18

68

M

lung

primary

Adenoca

COPD

COPD

70

NA

NA

NA

NA

19

79

M

lung

primary

SqCC

emphysema

AAA

90

520

NA

NA

NA

20

64

F

lung

primary

Adenoca

No

CRF/IHD

90

wnl

wnl

2.04

1.56

21

76

F

lung

primary

SCLC

No

bladder ca./breast ca.

90

wnl

wnl

2.17

1.59

22

77

M

lung

primary

SqCC

No

diabetic nephropathy

80

wnl

wnl

NA

NA

23

78

M

lung

primary

NSCLC

IP

IP

80

wnl

127

NA

NA

24

62

M

colon

metastasis

Unknown

No

colon ca.

90

wnl

wnl

3.69

2.87

25

78

F

lung

primary

Carcinoma

IP/post lobectomy

post lobectomy

90

wnl

wnl

1.54

0.99

         

(0–500)

(0–110)

  
  1. AAA: abdominal aortic aneurysm, Adenoca: adenocarcinoma, ca.: cancer, COPD: chronic obstructive pulmonary disea
  2. ED: extended disease, FEV: forced expiratory volume, HCC: hepatocellular carcinoma, IHD: ischemic heart disease, IP?
  3. K-PS: karnofsky performance status scale, M valve: mitral valve, NA: not available, s: serum, TAA: thoracic aortic ane
  4. RP: radiation pneumonitis, SCLC:small cell lung cancer, SP-D: surfactant protein-D, SqCC: squamous cell carcinoma,